Email This Article

Neurocrine Says Sleeping Pill Data Are Good
By Adam Feuerstein
11/14/02 - 09:50 AM EST
The company may get a marketing agreement soon and compete against Ambien.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.00 1,107.93 2,201.05 35.82
Oil *
72.85
DOWN
49.05
DOWN
6.18
DOWN
11.05
DOWN
0.21
10 Yr
3.58%
SPDR Gold
110.21
-0.47%
-0.55%
-0.50%
-0.58%
Data delayed 20 minutes

Brokerage Partners